Brian McNabb

434 total citations
15 papers, 193 citations indexed

About

Brian McNabb is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Brian McNabb has authored 15 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 5 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Brian McNabb's work include Hepatitis C virus research (5 papers), Bone health and osteoporosis research (3 papers) and Bone health and treatments (2 papers). Brian McNabb is often cited by papers focused on Hepatitis C virus research (5 papers), Bone health and osteoporosis research (3 papers) and Bone health and treatments (2 papers). Brian McNabb collaborates with scholars based in United States, United Kingdom and Vietnam. Brian McNabb's co-authors include Warren Isakow, Douglas C. Bauer, Dennis M. Black, Richard Eastell, Kristine E. Ensrud, Eric Vittinghoff, Kosh Agarwal, Elizabeth Barrett‐Connor, Ann V. Schwartz and Jean‐François Dufour and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Journal of Hepatology.

In The Last Decade

Brian McNabb

14 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian McNabb United States 7 80 76 71 56 28 15 193
Philip G. Ferstl Germany 9 162 2.0× 169 2.2× 5 0.1× 26 0.5× 20 0.7× 18 280
Kolja Eckert Germany 8 65 0.8× 142 1.9× 22 0.3× 10 0.2× 51 1.8× 10 325
A Ramani India 8 25 0.3× 60 0.8× 4 0.1× 11 0.2× 8 0.3× 24 182
G. Elia Italy 8 125 1.6× 102 1.3× 3 0.0× 9 0.2× 26 0.9× 18 288
Emanuela Messina Italy 10 104 1.3× 116 1.5× 4 0.1× 13 0.2× 23 0.8× 37 224
Larisa Vasilieva Greece 10 143 1.8× 148 1.9× 3 0.0× 7 0.1× 34 1.2× 20 239
Tom Hosack United Kingdom 5 24 0.3× 27 0.4× 7 0.1× 26 0.5× 19 0.7× 8 299
М. С. Жаркова Russia 8 52 0.7× 114 1.5× 42 0.8× 86 3.1× 39 231
John Almeida Australia 5 43 0.5× 45 0.6× 1 0.0× 30 0.5× 34 1.2× 8 172
Alejandro Campos-Murguía Mexico 8 76 0.9× 109 1.4× 15 0.3× 18 0.6× 26 248

Countries citing papers authored by Brian McNabb

Since Specialization
Citations

This map shows the geographic impact of Brian McNabb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian McNabb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian McNabb more than expected).

Fields of papers citing papers by Brian McNabb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian McNabb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian McNabb. The network helps show where Brian McNabb may publish in the future.

Co-authorship network of co-authors of Brian McNabb

This figure shows the co-authorship network connecting the top 25 collaborators of Brian McNabb. A scholar is included among the top collaborators of Brian McNabb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian McNabb. Brian McNabb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Agarwal, Kosh, Lluı́s Castells, Beat Müllhaupt, et al.. (2018). Sofosbuvir/velpatasvir for 12 weeks in genotype 1–4 HCV-infected liver transplant recipients. Journal of Hepatology. 69(3). 603–607. 49 indexed citations
3.
Pineda, John, Rosa M. Morillas, J.M. Pascasio, et al.. (2018). Safety and efficacy of Sofosbuvir/Velpatasvir with and without Ribavirin in genotype 3HCV-infected patients with cirrhosis. Journal of Hepatology. 68. S20–S21. 3 indexed citations
4.
Wyles, David, Eric Lawitz, Brian McNabb, et al.. (2018). 720 - Emergence and Long-Term Persistence of NS3, NS5A, and NS5B Resistance Associated Substitutions after Treatment with Direct-Acting Antivirals. Gastroenterology. 154(6). S–1104. 1 indexed citations
5.
Muir, Andrew J., Alessandra Mangia, Eric Lawitz, et al.. (2018). 290 - Long-Term Follow-Up of Patients with Chronic HCV Infection and Compensated or Decompensated Cirrhosis Following Treatment with Sofosbuvir-Based Regimens. Gastroenterology. 154(6). S–1081. 6 indexed citations
6.
Jacobson, Ira M., Stefan Zeuzem, Edward Gane, et al.. (2018). 291 - Long-Term Follow-Up of Patients with Chronic HCV and F2 or F3 Fibrosis after Achieving SVR with Daa-Based Therapy: Results from the Gilead SVR Registry. Gastroenterology. 154(6). S–1081. 1 indexed citations
7.
Kim, Tiffany Y., Douglas C. Bauer, Brian McNabb, et al.. (2018). Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials. Journal of Bone and Mineral Research. 34(5). 810–816. 26 indexed citations
8.
Lawitz, Eric, Brian McNabb, Anu Osinusi, et al.. (2018). Emergence and long-term persistence of NS3, NS5A, and NS5B resistance associated substitutions after treatment with direct-acting antivirals. Journal of Hepatology. 68. S254–S254.
9.
Mangia, Alessandra, E. Läwitz, Edward Gane, et al.. (2018). Long-term follow-up of patients with chronic HCV infection and compensated or decompensated cirrhosis following treatment with sofosbuvir-based regimens. Journal of Hepatology. 68. S67–S68. 13 indexed citations
10.
Bourlière, Marc, Edward Gane, Stuart C. Gordon, et al.. (2017). Long-term follow up of patients with chronic HCV and no or minimal fibrosis shows low risk for liver-related morbidity and mortality after achieving SVR with DAA-based therapy: Results from the gilead SVR registry.. 66. 5 indexed citations
11.
Pettus, Jeremy, Brian McNabb, Robert H. Eckel, et al.. (2016). Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin. Diabetes Obesity and Metabolism. 18(5). 463–474. 13 indexed citations
12.
McNabb, Brian, Eric Vittinghoff, Richard Eastell, et al.. (2014). A Model of BMD Changes After Alendronate Discontinuation to Guide Postalendronate BMD Monitoring. The Journal of Clinical Endocrinology & Metabolism. 99(11). 4094–4100. 9 indexed citations
13.
Cascino, Matthew D., Brian McNabb, David G. Gardner, et al.. (2013). Acute Liver Failure with Thyrotoxicosis Treated with Liver Transplantation. Endocrine Practice. 19(3). e57–e60. 2 indexed citations
14.
McNabb, Brian, Eric Vittinghoff, Ann V. Schwartz, et al.. (2013). BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate. Journal of Bone and Mineral Research. 28(6). 1319–1327. 41 indexed citations
15.
McNabb, Brian & Warren Isakow. (2008). Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. Current Opinion in Pulmonary Medicine. 14(3). 168–175. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip G. Ferstl Breakdown of academic impact, for papers by Kolja Eckert Breakdown of academic impact, for papers by A Ramani Breakdown of academic impact, for papers by G. Elia Breakdown of academic impact, for papers by Emanuela Messina Breakdown of academic impact, for papers by Larisa Vasilieva Breakdown of academic impact, for papers by Tom Hosack Breakdown of academic impact, for papers by М. С. Жаркова Breakdown of academic impact, for papers by John Almeida Breakdown of academic impact, for papers by Alejandro Campos-Murguía
Rankless by CCL
2026